⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7939503 | 0.96 | — | — | |
| SCHEMBL5243914 | 0.72 | — | — | |
| SCHEMBL21120532 | 0.72 | — | — | |
| SCHEMBL10090955 | 0.72 | — | — | |
| SCHEMBL10090943 | 0.72 | — | — | |
| SCHEMBL12974438 | 0.72 | — | — | |
| SCHEMBL12974391 | 0.72 | — | — | |
| SCHEMBL21349135 | 0.72 | — | — | |
| SCHEMBL13416938 | 0.72 | — | — | |
| SCHEMBL14947751 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250379224-A1 | SILICON DOMINANT ANODES CONTAINING PYROLYZED CARBON | ENEVATE CORP (US) | 2025-12-11 | — | — | US | claimed |
| EP-4649102-A1 | REINFORCED ANION EXCHNAGE MEMBRANES AND METHODS OF MAKING SAME | Orion Polymer Corp. (US) | 2025-11-19 | — | — | EP | claimed |
| CN-120136646-A | Method for synthesizing benzyl alkyl ketone compound by visible light catalysis | 中国科学院化学研究所 | 2025-06-13 | — | — | CN | claimed |
| US-12113200-B2 | Method and system for water soluble weak acidic resins as carbon precursors for silicon-dominant anodes | ENEVATE CORPORATION (US) | 2024-10-08 | — | — | US | claimed |
| WO-2024151961-A1 | REINFORCED ANION EXCHNAGE MEMBRANES AND METHODS OF MAKING SAME | ORION POLYMER CORP. (US) | 2024-07-18 | — | — | WO | claimed |
| US-20240186553-A1 | Benzimidazole-Based Polymer Electrolyte Membrane Having High Ionic Conductivity Under High Temperature and Non-Humidified Conditions and Method for Preparing Same | KIA CORPORATION (KR) | 2024-06-06 | — | — | US | claimed |
| CN-115073743-B | Modified organic silicon polymer material and preparation method thereof | 杭州琼天新材料科技有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-115073743-A | Modified organic silicon high polymer material and preparation method thereof | 杭州琼天新材料科技有限公司 | 2022-09-20 | — | — | CN | claimed |
| US-20210384487-A1 | METHOD AND SYSTEM FOR WATER SOLUBLE WEAK ACIDIC RESINS AS CARBON PRECURSORS FOR SILICON-DOMINANT ANODES | ENEVATE CORPORATION | 2021-12-09 | — | — | US | claimed |
| CN-110655451-B | Method for preparing hydroxyl and trifluoromethyl substituted compound by reaction of olefin and trifluorobromomethane | 中山大学 | 2020-10-27 | — | — | CN | claimed |
| EP-1656355-B1 | PIPERAZINE DERIVATIVES AND METHODS OF USE | AMGEN INC (US) | 2008-03-12 | — | — | EP | claimed |
| EP-1878728-A2 | Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders | Amgen Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1817306-A1 | TRIAZOLES AND THEIR USE AS BRADYKININ B1 RECEPTOR ANTAGONISTS | Amgen, Inc (US) | 2007-08-15 | — | — | EP | claimed |
| US-20060111347-A1 | Substituted sulfones and methods of use | AMGEN INC. (US) | 2006-05-25 | — | — | US | claimed |
| EP-1656355-A2 | PIPERAZINE DERIVATIVES AND METHODS OF USE | AMGEN INC. (US) | 2006-05-17 | — | — | EP | claimed |
| US-20060100213-A1 | Triazoles and methods of use | AMGEN INC. (US) | 2006-05-11 | — | — | US | claimed |
| US-20060100216-A1 | Novel B1 bradykinin receptor antagonists | AMGEN INC. (US) | 2006-05-11 | — | — | US | claimed |
| WO-2006044355-A1 | TRIAZOLES AND THEIR USE AS BRADYKININ B1 RECEPTOR ANTAGONISTS | AMGEN INC. (US) | 2006-04-27 | — | — | WO | claimed |
| WO-2005061467-A2 | PIPERAZINE DERIVATIVES AS BRADYKININ ANTAGONISTS | AMGEN INC. (US) | 2005-07-07 | — | — | WO | claimed |
| US-20050014749-A1 | analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects | AMGEN INC. | 2005-01-20 | — | — | US | claimed |